Inozyme Pharma, Inc. (INZY)

USD 2.76

(-6.12%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 200.84 Million 139.19 Million 123.54 Million 169.36 Million 47.94 Million 43.54 Million
Total Current Assets 196.25 Million 131.39 Million 115.34 Million 150.97 Million 47.46 Million 43.26 Million
Cash And Short Term Investments 188.58 Million 127.86 Million 111.8 Million 159.89 Million 47.13 Million 43.16 Million
Cash and Cash Equivalents 34.58 Million 32.91 Million 23.31 Million 159.89 Million 31.6 Million 35.96 Million
Short Term Investments 154 Million 94.95 Million 88.48 Million 119.65 Million 15.52 Million 7.19 Million
Net Receivables 385 Thousand 115 Thousand 62 Thousand 155 Thousand 104 Thousand 31 Thousand
Inventory - -115 Thousand -62 Thousand -12.35 Million - -
Other Current Assets 7.27 Million 3.52 Million 3.54 Million 3.28 Million 224 Thousand 73 Thousand
Total Non-Current Assets 4.59 Million 7.8 Million 8.19 Million 18.38 Million 484 Thousand 276 Thousand
Net PPE 2.59 Million 3.63 Million 4.43 Million 2.64 Million 298 Thousand 242 Thousand
Good Will And Intangible Assets - - - - - -
Good Will - - - - - -
Intangible Assets - - - - - -
Long-Term Investments 311 Thousand 354 Thousand 354 Thousand 12.19 Million 130 Thousand -
Tax Assets - - - - - -
Other Non Current Assets 1.69 Million 3.81 Million 3.4 Million 3.53 Million 56 Thousand 34 Thousand
Other Assets - - - - - -
Total Liabilities 60.36 Million 20.8 Million 14.27 Million 11.26 Million 81.16 Million 57.41 Million
Total Current Liabilities 14.68 Million 14.71 Million 11.63 Million 9.97 Million 3.23 Million 2.38 Million
Account Payables 1.16 Million 2.54 Million 2.39 Million 3.06 Million 901 Thousand 984 Thousand
Tax Payables - - - - - -
Short Term Debt 910 Thousand 816 Thousand 731 Thousand -279 Thousand - -
Deferred Revenue - 3.81 Million - 279 Thousand - -
Other Current Liabilities 12.61 Million 7.54 Million 8.5 Million 6.9 Million 2.33 Million 1.4 Million
Total Non Current Liabilities 45.68 Million 6.08 Million 2.64 Million 1.28 Million 77.92 Million 55.02 Million
Long-Term Debt 44.76 Million 5.96 Million 2.64 Million 1.28 Million - -
Deferred Revenue Non Current - - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 913 Thousand 124 Thousand - - - 55.02 Million
Other Liabilities - - - - - -
Total Equity 140.47 Million 118.59 Million 109.26 Million 158.09 Million -33.21 Million -13.87 Million
Stock Holders Equity 140.47 Million 118.59 Million 109.26 Million 158.09 Million -33.21 Million -13.87 Million
Common Stock 6000.00 4000.00 2000.00 2000.00 1000.00 1000.00
Retained Earnings -285.93 Million -214.76 Million -147.7 Million -91.07 Million -34.65 Million -14.92 Million
Accumulated other comprehensive income 41 Thousand -205 Thousand 18 Thousand 2000.00 5000.00 -2000.00
Common Stock Equity 140.47 Million 118.59 Million 109.26 Million 158.09 Million -33.21 Million -13.87 Million
Capital Lease Obligation 913 Thousand 2.63 Million 3.37 Million 1.28 Million - -
Total Investments 154.31 Million 94.95 Million 88.48 Million 131.85 Million 15.52 Million 7.19 Million
Total Debt 46.59 Million 6.77 Million 3.37 Million 1.28 Million - -
Net Debt 12 Million -26.13 Million -19.94 Million -158.6 Million -31.6 Million -35.96 Million

Balance Sheet Charts